2,5-Dimethoxy-4-methylphenylcyclopropylamine

2,5-Dimethoxy-4-methylphenylcyclopropylamine
Names
	IUPAC name 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine
Identifiers
CAS Number	69854-49-5 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL13530 ;
ChemSpider	2285590 ;
PubChem CID	3017965;
CompTox Dashboard (EPA)	DTXSID10990120 ;
	InChI InChI=1S/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 Key: HYVPPECPQRBJEQ-UHFFFAOYSA-N ; InChI=1/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 Key: HYVPPECPQRBJEQ-UHFFFAOYAN;
	SMILES O(c1c(cc(OC)c(c1)C2CC2N)C)C;
Properties
Chemical formula	C12H17NO2
Molar mass	207.27 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

DMCPA, or 4-methyl-2,5-methoxy phenyl cyclopropyl amine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–20 mg, and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.